Cargando…
Video directly observed therapy intervention using a mobile health application among opioid use disorder patients receiving office-based buprenorphine treatment: protocol for a pilot randomized controlled trial
BACKGROUND: Office-based buprenorphine treatment of opioid use disorder (OUD) does not typically include in-person directly observed therapy (DOT), potentially leading to non-adherence. Video DOT technologies may safeguard against this issue and thus enhance likelihood of treatment success. We descr...
Autores principales: | Schramm, Zachery A., Leroux, Brian G., Radick, Andrea C., Ventura, Alicia S., Klein, Jared W., Samet, Jeffrey H., Saxon, Andrew J., Kim, Theresa W., Tsui, Judith I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7393902/ https://www.ncbi.nlm.nih.gov/pubmed/32736660 http://dx.doi.org/10.1186/s13722-020-00203-9 |
Ejemplares similares
-
Timing of hepatitis C treatment initiation and retention in office-based opioid treatment with buprenorphine: a retrospective cohort study
por: Geist, Mary L., et al.
Publicado: (2023) -
Treating Homeless Opioid Dependent Patients with Buprenorphine in an Office-Based Setting
por: Alford, Daniel P., et al.
Publicado: (2007) -
Buprenorphine Dosage and Urine Quantitative Buprenorphine, Norbuprenorphine, and Creatinine Levels in an Office-Based Opioid Treatment Program
por: Furo, Hiroko, et al.
Publicado: (2021) -
Provider and patient perspectives on barriers to buprenorphine adherence and the acceptability of video directly observed therapy to enhance adherence
por: Godersky, Margo E., et al.
Publicado: (2019) -
Characterizing opioid use disorder patients who have received medication trials with both buprenorphine and methadone
por: Wilder, Christine M, et al.
Publicado: (2015)